Fig. 10

Effectiveness of ADME-related signature in predicting drug sensitivity. (A). Bubble plot of the relationship between drugs and model genes. Boxplots of the comparison of IC50 of drugs between high- and low-risk groups, and correlation between the IC50 and risk score in TCGA-KIRC cohort: (B) Sunitinib; (C) Sorafenib; (D) Rapamycin; (E) Imatinib; (F) Erlotinib; (G) Bleomycin.